Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Monoclonal Antibodies In Veterinary Health Market, by Region, 2019-2029 (USD Billion)
1.2.2. Monoclonal Antibodies In Veterinary Health Market, by Animal Type, 2019-2029 (USD Billion)
1.2.3. Monoclonal Antibodies In Veterinary Health Market, by Application, 2019-2029 (USD Billion)
1.2.4. Monoclonal Antibodies In Veterinary Health Market, by End-User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Monoclonal Antibodies In Veterinary Health Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Monoclonal Antibodies In Veterinary Health Market Dynamics
3.1. Monoclonal Antibodies In Veterinary Health Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Growing pet population
3.1.1.2. Increasing expenditure on pet
3.1.2. Market Challenges
3.1.2.1. Lack of awareness
3.1.2.2. Several problems are associated with the Monoclonal Antibodies
3.1.3. Market Opportunities
3.1.3.1. Increasing number of initiatives by government and various private organizations
3.1.3.2. Growing investment in the R&D activities
Chapter 4. Global Monoclonal Antibodies In Veterinary Health Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Monoclonal Antibodies In Veterinary Health Market, by Animal Type
6.1. Market Snapshot
6.2. Global Monoclonal Antibodies In Veterinary Health Market by Animal Type, Performance - Potential Analysis
6.3. Global Monoclonal Antibodies In Veterinary Health Market Estimates & Forecasts by Animal Type, 2019-2029 (USD Billion)
6.4. Monoclonal Antibodies In Veterinary Health Market, Sub Segment Analysis
6.4.1. Dogs
6.4.2. Others
Chapter 7. Global Monoclonal Antibodies In Veterinary Health Market, by Application
7.1. Market Snapshot
7.2. Global Monoclonal Antibodies In Veterinary Health Market by Application, Performance - Potential Analysis
7.3. Global Monoclonal Antibodies In Veterinary Health Market Estimates & Forecasts by Application, 2019-2029 (USD Billion)
7.4. Monoclonal Antibodies In Veterinary Health Market, Sub Segment Analysis
7.4.1. Dermatology
7.4.2. Pain
7.4.3. Others
Chapter 8. Global Monoclonal Antibodies In Veterinary Health Market, by End-User
8.1. Market Snapshot
8.2. Global Monoclonal Antibodies In Veterinary Health Market by End-User, Performance - Potential Analysis
8.3. Global Monoclonal Antibodies In Veterinary Health Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
8.4. Monoclonal Antibodies In Veterinary Health Market, Sub Segment Analysis
8.4.1. Veterinary Hospitals
8.4.2. Others
Chapter 9. Global Monoclonal Antibodies In Veterinary Health Market, Regional Analysis
9.1. Monoclonal Antibodies In Veterinary Health Market, Regional Market Snapshot
9.2. North America Monoclonal Antibodies In Veterinary Health Market
9.2.1. U.S. Monoclonal Antibodies In Veterinary Health Market
9.2.1.1. Animal Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
9.2.1.3. End-User breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Monoclonal Antibodies In Veterinary Health Market
9.3. Europe Monoclonal Antibodies In Veterinary Health Market Snapshot
9.3.1. U.K. Monoclonal Antibodies In Veterinary Health Market
9.3.2. Germany Monoclonal Antibodies In Veterinary Health Market
9.3.3. France Monoclonal Antibodies In Veterinary Health Market
9.3.4. Spain Monoclonal Antibodies In Veterinary Health Market
9.3.5. Italy Monoclonal Antibodies In Veterinary Health Market
9.3.6. Rest of Europe Monoclonal Antibodies In Veterinary Health Market
9.4. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market Snapshot
9.4.1. China Monoclonal Antibodies In Veterinary Health Market
9.4.2. India Monoclonal Antibodies In Veterinary Health Market
9.4.3. Japan Monoclonal Antibodies In Veterinary Health Market
9.4.4. Australia Monoclonal Antibodies In Veterinary Health Market
9.4.5. South Korea Monoclonal Antibodies In Veterinary Health Market
9.4.6. Rest of Asia Pacific Monoclonal Antibodies In Veterinary Health Market
9.5. Latin America Monoclonal Antibodies In Veterinary Health Market Snapshot
9.5.1. Brazil Monoclonal Antibodies In Veterinary Health Market
9.5.2. Mexico Monoclonal Antibodies In Veterinary Health Market
9.6. Rest of The World Monoclonal Antibodies In Veterinary Health Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Zoetis
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Merck & Co, Inc.
10.2.3. Elanco Animal Health
10.2.4. Phibro Animal Health Corporation
10.2.5. Boehringer Ingelheim GmbH
10.2.6. Indian Immunologicals Ltd
10.2.7. Virbac
10.2.8. American Animal Health, Inc.
10.2.9. Hester Biosciences Limited
10.2.10. Colorado Serum Company
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption